BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhi X, Wang L, Chen H, Fang C, Cui J, Hu Y, Cao L, Weng W, Zhou Q, Qin L, Song H, Wang Y, Wang Y, Jiang H, Li X, Wang S, Chen X, Su J. l-tetrahydropalmatine suppresses osteoclastogenesis in vivo and in vitro via blocking RANK-TRAF6 interactions and inhibiting NF-κB and MAPK pathways. J Cell Mol Med 2020;24:785-98. [PMID: 31725199 DOI: 10.1111/jcmm.14790] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Lin B, Xu P, Zheng J, Deng X, Ye Q, Huang Z, Wang N. Effects and mechanisms of natural alkaloids for prevention and treatment of osteoporosis. Front Pharmacol 2022;13:1014173. [DOI: 10.3389/fphar.2022.1014173] [Reference Citation Analysis]
2 Xia J, Wan Y, Wu JJ, Yang Y, Xu JF, Zhang L, Liu D, Chen L, Tang F, Ao H, Peng C. Therapeutic potential of dietary flavonoid hyperoside against non-communicable diseases: targeting underlying properties of diseases. Crit Rev Food Sci Nutr 2022;:1-31. [PMID: 36073729 DOI: 10.1080/10408398.2022.2115457] [Reference Citation Analysis]
3 Liao HH, Livneh H, Chung YJ, Lin CH, Lai NS, Yen HR, Tsai TY. A Comparison of the Risk of Fracture in Rheumatoid Arthritis Patients with and without Receiving Chinese Herbal Medicine. J Multidiscip Healthc 2021;14:3399-409. [PMID: 34934326 DOI: 10.2147/JMDH.S334134] [Reference Citation Analysis]
4 Deng W, Ding Z, Wang Y, Zou B, Zheng J, Tan Y, Yang Q, Ke M, Chen Y, Wang S, Li X. Dendrobine attenuates osteoclast differentiation through modulating ROS/NFATc1/ MMP9 pathway and prevents inflammatory bone destruction. Phytomedicine 2021;:153838. [PMID: 34801352 DOI: 10.1016/j.phymed.2021.153838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Woźniczka M, Błaszczak-Świątkiewicz K. New Generation of Meso and Antiprogestins (SPRMs) into the Osteoporosis Approach. Molecules 2021;26:6491. [PMID: 34770897 DOI: 10.3390/molecules26216491] [Reference Citation Analysis]
6 Ma C, Sheng N, Shi G, Zhang J, Zhang T. An efficient approach to probe the bioactive transdermal components of traditional Chinese herbal patches by UHPLC-MS: Gutong patch as a case. Phytomedicine 2021;93:153776. [PMID: 34666285 DOI: 10.1016/j.phymed.2021.153776] [Reference Citation Analysis]
7 Wang Y, Zhu W, Lu D, Zhang C, Wang Y. Tetrahydropalmatine attenuates MSU crystal-induced gouty arthritis by inhibiting ROS-mediated NLRP3 inflammasome activation. Int Immunopharmacol 2021;100:108107. [PMID: 34482265 DOI: 10.1016/j.intimp.2021.108107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cang D, Zou G, Yang C, Shen X, Li F, Wu Y, Ji B. Dencichine prevents ovariectomy-induced bone loss and inhibits osteoclastogenesis by inhibiting RANKL-associated NF-κB and MAPK signaling pathways. J Pharmacol Sci 2021;146:206-15. [PMID: 34116734 DOI: 10.1016/j.jphs.2021.04.004] [Reference Citation Analysis]
9 Huang MZ, Zhuang Y, Ning X, Zhang H, Shen ZM, Shang XW. Artesunate inhibits osteoclastogenesis through the miR-503/RANK axis. Biosci Rep 2020;40:BSR20194387. [PMID: 32542308 DOI: 10.1042/BSR20194387] [Reference Citation Analysis]
10 Deng AP, Zhang Y, Zhou L, Kang CZ, Lv CG, Kang LP, Nan TG, Zhan ZL, Guo LP, Huang LQ. Systematic review of the alkaloid constituents in several important medicinal plants of the Genus Corydalis. Phytochemistry 2021;183:112644. [PMID: 33429352 DOI: 10.1016/j.phytochem.2020.112644] [Reference Citation Analysis]
11 Wang J, Tang Y, Lv X, Zhang J, Ma B, Wen X, Bao Y, Wang G. Tectoridin inhibits osteoclastogenesis and bone loss in a murine model of ovariectomy-induced osteoporosis. Exp Gerontol 2020;140:111057. [PMID: 32798609 DOI: 10.1016/j.exger.2020.111057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Liu Y, Xu Z, Wang Q, Jiang Y, Wang R, Chen S, Zhu J, Zhang Y, Chen J. Selective regulation of RANKL/RANK/OPG pathway by heparan sulfate through the binding with estrogen receptor β in MC3T3-E1 cells. International Journal of Biological Macromolecules 2020;161:1526-34. [DOI: 10.1016/j.ijbiomac.2020.07.308] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Li Z, Li S, Wang N, Xue P, Li Y. Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the inhibition of NF-κB and MAPK pathways via GLP-1R. Biomed Pharmacother 2020;130:110523. [PMID: 32702632 DOI: 10.1016/j.biopha.2020.110523] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Lu J, Ye C, Huang Y, Huang D, Tang L, Hou W, Kuang Z, Chen Y, Xiao S, Yishake M, He R. Corilagin suppresses RANKL-induced osteoclastogenesis and inhibits oestrogen deficiency-induced bone loss via the NF-κB and PI3K/AKT signalling pathways. J Cell Mol Med 2020;24:10444-57. [PMID: 32681612 DOI: 10.1111/jcmm.15657] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Zeng J, Guo J, Sun Z, Deng F, Ning C, Xie Y. Osteoblastic and anti-osteoclastic activities of strontium-substituted silicocarnotite ceramics: In vitro and in vivo studies. Bioact Mater 2020;5:435-46. [PMID: 32280833 DOI: 10.1016/j.bioactmat.2020.03.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 10.5] [Reference Citation Analysis]
16 Cheng L, Zhu Y, Ke D, Xie D. Oestrogen-activated autophagy has a negative effect on the anti-osteoclastogenic function of oestrogen. Cell Prolif 2020;53:e12789. [PMID: 32157750 DOI: 10.1111/cpr.12789] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
17 Zhi X, Wang L, Chen H, Fang C, Cui J, Hu Y, Cao L, Weng W, Zhou Q, Qin L, Song H, Wang Y, Wang Y, Jiang H, Li X, Wang S, Chen X, Su J. l-tetrahydropalmatine suppresses osteoclastogenesis in vivo and in vitro via blocking RANK-TRAF6 interactions and inhibiting NF-κB and MAPK pathways. J Cell Mol Med 2020;24:785-98. [PMID: 31725199 DOI: 10.1111/jcmm.14790] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]